Hepatic toxicity resulting from cancer treatment

…, MS Anscher, RL Jirtle, WD Ensminger… - International Journal of …, 1995 - Elsevier
Radiation-induced liver disease (RILD), often called radiation hepatitis, is a syndrome
characterized by the development of anicteric ascites approximately 2 weeks to 4 months after …

A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil

WD Ensminger, A Rosowsky, V Raso, DC Levin… - Cancer research, 1978 - AACR
We have attempted to evaluate the degree to which hepatic arterial infusion of 5-fluoro-2′-deoxyuridine
(FdUrd) or 5-fluorouracil produces higher hepatic and lower systemic drug …

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

…, WD Ensminger, JF Gibbs, D Laheru… - Journal of the …, 2009 - europepmc.org
Hepatobiliary cancers are highly lethal. In 2008, approximately 21,370 persons in the United
States were estimated to be diagnosed with liver or intrahepatic bile duct cancer and 9520 …

The use of 3-D dose volume analysis to predict radiation hepatitis

…, DJMA Duross, JC Andrews, WD Ensminger… - International Journal of …, 1992 - Elsevier
Although it is well known that the tolerance of the liver to external beam irradiation depends
on the volume of liver irradiated, few data exist which quantify this dependence. Therefore, a …

[PDF][PDF] Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

E Ben-Josef, D Normolle, WD Ensminger… - Journal of clinical …, 2005 - researchgate.net
… Concurrent continuous-infusion hepatic arterial floxuridine (0.2 mg/kg/d) was delivered as
described, typically through a percutaneous hepatic arterial catheter placed through the …

[PDF][PDF] Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up

…, LA Cotton, WD Ensminger… - Journal of Nuclear …, 1994 - Soc Nuclear Med
RESULTS Two patients had functioning surgically implanted he patic artery catheters which
were used for microsphere administration. The remaining 22patients were treated us ing a …

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.

CJ McGinn, RK Ten Haken, WD Ensminger… - Journal of clinical …, 1998 - ascopubs.org
PURPOSE To attempt to safely escalate the dose of radiation for patients with intrahepatic
cancer, we designed a protocol in which each patient received the maximum possible dose …

Hepatobiliary cancers, version 2.2014

…, WD Ensminger, R Iyer, RK Kelley, D Linehan… - Journal of the National …, 2014 - jnccn.org
Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular
carcinoma), gall bladder, and bile ducts (cholangiocarcinomas). Gallbladder cancer …

N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers

…, MV Chevliakov, DS Shewach, WD Ensminger… - Biomaterials, 2011 - Elsevier
There is an urgent need for novel polymeric carriers that can selectively deliver a large dose
of chemotherapeutic agents into hepatic cancer cells to achieve high therapeutic activity …

Intrahepatic arterial infusion of chemotherapy: pharmacologic principles

WD Ensminger - Seminars in oncology, 2002 - Elsevier
Hepatic arterial (HA) infusional chemotherapy possesses a number of constraints not found
with systemic chemotherapy. The drug used should have activity in a dose-responsive way …